×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TELO – telomir pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TELO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:21 am
telo
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 [Yahoo! Finance]
Low
Report
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 [Yahoo! Finance]
11/21
07:00 am
telo
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Low
Report
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
9/26
04:00 pm
telo
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Medium
Report
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
9/19
09:09 am
telo
Telomir Pharmaceuticals Insider Ups Holding During Year [Yahoo! Finance]
High
Report
Telomir Pharmaceuticals Insider Ups Holding During Year [Yahoo! Finance]
9/4
07:30 am
telo
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
High
Report
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
04:16 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 18
Low
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 18
11/20
04:16 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 20
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 20
11/12
04:06 pm
telo
Form 10-Q Telomir Pharmaceuticals, For: Sep 30
Medium
Report
Form 10-Q Telomir Pharmaceuticals, For: Sep 30
9/27
04:15 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Sep 27
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Sep 27
9/4
01:37 pm
telo
Form 4 Telomir Pharmaceuticals, For: Aug 27 Filed by: Yanez Michelle
Low
Report
Form 4 Telomir Pharmaceuticals, For: Aug 27 Filed by: Yanez Michelle
9/3
04:37 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Sep 03
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Sep 03
8/29
04:06 pm
telo
Form 4 Telomir Pharmaceuticals, For: Aug 27 Filed by: Jerman Michael Allen
Medium
Report
Form 4 Telomir Pharmaceuticals, For: Aug 27 Filed by: Jerman Michael Allen
8/29
04:06 pm
telo
Form 4 Telomir Pharmaceuticals, For: Aug 27 Filed by: MacPherson Edward Clouston
Medium
Report
Form 4 Telomir Pharmaceuticals, For: Aug 27 Filed by: MacPherson Edward Clouston
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: